Open Access Open Access  Restricted Access Subscription Access

A Fundamental Parameters of MMR Vaccine Include Indications, Mechanism of Action, Administration, Adverse Effects, Contra Indications, Relative Contra Indications and Toxicity

Srinivas G., Ramanjaneyulu D. V., Muralinath E., Guruprasad M., Sravani Pragna K., Manjari P., Sony Sharlet E., T. Nikhil, V. Yaswanth Sai, D. Kusuma latha, Ch. Ramya Sudha, Sridevi K, D. Gokul Shiva Balaji

Abstract


As approved by the US Food and Drug Administration (FDA), measles-containing vaccinations are used to vaccinate children and adolescents on a regular basis. Adults born after 1970 who have not received these vaccinations are likewise strongly advised to do so. Adults born prior to 1970 are typically considered to have developed a natural immunity to measles. Regardless of the situation, vulnerable individuals, including healthcare workers, military people, and visitors from outside North America, should have the measles, mumps, and rubella (MMR) vaccine to protect against very high risk of infection.

In order to create a less virulent and innocuous version of the infectious pathogens it targets; the MMR vaccine was developed in conjunction with live attenuated viruses. This vaccination is designed to boost immunity and prevent infectious diseases like rubella, mumps, and measles. The MMR vaccination is highly effective due to its live attenuated nature, but it requires several doses to get full immunity. Additionally, as a post-exposure prophylactic, this vaccination is strongly advised, especially for certain patient populations. In order to help the interprofessional healthcare team members safely administer the MMR vaccine to patients, this activity provides an overview of the vaccine's indications. In order to improve patient outcomes by boosting MMR vaccination uptake and preventing related illnesses, this effort attempts to equip medical personnel with the fundamental understanding of vaccine administration.


Full Text:

PDF

References


Marin M, Broder KR, Temte JL, Snider DE, Seward JF., Centers for Disease Control and Prevention (CDC). Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010 May 07;59(RR-3):1-12.

McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS., Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.

Strikas RA., Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP). ACIP Child/Adolescent Immunization Work Group. Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years--United States, 2015. MMWR Morb Mortal Wkly Rep. 2015 Feb 06;64(4):93-4.

Drugs and Lactation Database (LactMed®) [Internet]. National Institute of Child Health and Human Development; Bethesda (MD): Aug 15, 2024. Measles-Mumps-Rubella Vaccine.

Psarris A, Sindos M, Daskalakis G, Chondrogianni ME, Panayiotou S, Antsaklis P, Loutradis D. Immunizations during pregnancy: How, when and why. Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:29-35.

Krow-Lucal E, Marin M, Shepersky L, Bahta L, Loehr J, Dooling K. Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 18;71(46):1465-1470.

MMR-162 Study Group. Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study. Hum Vaccin Immunother. 2018;14(12):2921-2931.

Abu-Elyazeed R, Jennings W, Severance R, Noss M, Caplanusi A, Povey M, Henry O. Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study. Hum Vaccin Immunother. 2018;14(11):2624-2631.

Danziger-Isakov L, Kumar D., AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019 Sep;33(9):e13563.

Niederer-Loher A. [Vaccinations in pregnancy – Don’t miss the opportunity!]. Ther Umsch. 2016;73(5):269-73.


Refbacks

  • There are currently no refbacks.